THE ROBERT H. LURIE Comprehensive Cancer Center of Northwestern University, the Northwestern Medicine Developmental Therapeutics Institute, and NeoGenomics Inc. entered into a research agreement with plans to initiate a translational program focused on expanding the use of genomic profiling technologies.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
